<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2008-03-18" modified="2020-10-07" version="139">
<accession>Q6N021</accession>
<accession>B5MDU0</accession>
<accession>Q2TB88</accession>
<accession>Q3LIB8</accession>
<accession>Q96JX5</accession>
<accession>Q9HCM6</accession>
<accession>Q9NXW0</accession>
<name>TET2_HUMAN</name>
<protein>
<recommendedName>
<fullName>Methylcytosine dioxygenase TET2</fullName>
<ecNumber evidence="21">1.14.11.n2</ecNumber>
</recommendedName>
</protein>
<gene>
<name type="primary">TET2</name>
<name type="synonym">KIAA1546</name>
<name type="ORF">Nbla00191</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="2007" name="BMC Genomics" volume="8" first="399" last="399">
<title>The full-ORF clone resource of the German cDNA consortium.</title>
<authorList>
<person name="Bechtel S."/>
<person name="Rosenfelder H."/>
<person name="Duda A."/>
<person name="Schmidt C.P."/>
<person name="Ernst U."/>
<person name="Wellenreuther R."/>
<person name="Mehrle A."/>
<person name="Schuster C."/>
<person name="Bahr A."/>
<person name="Bloecker H."/>
<person name="Heubner D."/>
<person name="Hoerlein A."/>
<person name="Michel G."/>
<person name="Wedler H."/>
<person name="Koehrer K."/>
<person name="Ottenwaelder B."/>
<person name="Poustka A."/>
<person name="Wiemann S."/>
<person name="Schupp I."/>
</authorList>
<dbReference type="PubMed" id="17974005"/>
<dbReference type="DOI" id="10.1186/1471-2164-8-399"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2)</scope>
<scope>VARIANT MET-218</scope>
<source>
<tissue>Fetal kidney</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="2005" name="Nature" volume="434" first="724" last="731">
<title>Generation and annotation of the DNA sequences of human chromosomes 2 and 4.</title>
<authorList>
<person name="Hillier L.W."/>
<person name="Graves T.A."/>
<person name="Fulton R.S."/>
<person name="Fulton L.A."/>
<person name="Pepin K.H."/>
<person name="Minx P."/>
<person name="Wagner-McPherson C."/>
<person name="Layman D."/>
<person name="Wylie K."/>
<person name="Sekhon M."/>
<person name="Becker M.C."/>
<person name="Fewell G.A."/>
<person name="Delehaunty K.D."/>
<person name="Miner T.L."/>
<person name="Nash W.E."/>
<person name="Kremitzki C."/>
<person name="Oddy L."/>
<person name="Du H."/>
<person name="Sun H."/>
<person name="Bradshaw-Cordum H."/>
<person name="Ali J."/>
<person name="Carter J."/>
<person name="Cordes M."/>
<person name="Harris A."/>
<person name="Isak A."/>
<person name="van Brunt A."/>
<person name="Nguyen C."/>
<person name="Du F."/>
<person name="Courtney L."/>
<person name="Kalicki J."/>
<person name="Ozersky P."/>
<person name="Abbott S."/>
<person name="Armstrong J."/>
<person name="Belter E.A."/>
<person name="Caruso L."/>
<person name="Cedroni M."/>
<person name="Cotton M."/>
<person name="Davidson T."/>
<person name="Desai A."/>
<person name="Elliott G."/>
<person name="Erb T."/>
<person name="Fronick C."/>
<person name="Gaige T."/>
<person name="Haakenson W."/>
<person name="Haglund K."/>
<person name="Holmes A."/>
<person name="Harkins R."/>
<person name="Kim K."/>
<person name="Kruchowski S.S."/>
<person name="Strong C.M."/>
<person name="Grewal N."/>
<person name="Goyea E."/>
<person name="Hou S."/>
<person name="Levy A."/>
<person name="Martinka S."/>
<person name="Mead K."/>
<person name="McLellan M.D."/>
<person name="Meyer R."/>
<person name="Randall-Maher J."/>
<person name="Tomlinson C."/>
<person name="Dauphin-Kohlberg S."/>
<person name="Kozlowicz-Reilly A."/>
<person name="Shah N."/>
<person name="Swearengen-Shahid S."/>
<person name="Snider J."/>
<person name="Strong J.T."/>
<person name="Thompson J."/>
<person name="Yoakum M."/>
<person name="Leonard S."/>
<person name="Pearman C."/>
<person name="Trani L."/>
<person name="Radionenko M."/>
<person name="Waligorski J.E."/>
<person name="Wang C."/>
<person name="Rock S.M."/>
<person name="Tin-Wollam A.-M."/>
<person name="Maupin R."/>
<person name="Latreille P."/>
<person name="Wendl M.C."/>
<person name="Yang S.-P."/>
<person name="Pohl C."/>
<person name="Wallis J.W."/>
<person name="Spieth J."/>
<person name="Bieri T.A."/>
<person name="Berkowicz N."/>
<person name="Nelson J.O."/>
<person name="Osborne J."/>
<person name="Ding L."/>
<person name="Meyer R."/>
<person name="Sabo A."/>
<person name="Shotland Y."/>
<person name="Sinha P."/>
<person name="Wohldmann P.E."/>
<person name="Cook L.L."/>
<person name="Hickenbotham M.T."/>
<person name="Eldred J."/>
<person name="Williams D."/>
<person name="Jones T.A."/>
<person name="She X."/>
<person name="Ciccarelli F.D."/>
<person name="Izaurralde E."/>
<person name="Taylor J."/>
<person name="Schmutz J."/>
<person name="Myers R.M."/>
<person name="Cox D.R."/>
<person name="Huang X."/>
<person name="McPherson J.D."/>
<person name="Mardis E.R."/>
<person name="Clifton S.W."/>
<person name="Warren W.C."/>
<person name="Chinwalla A.T."/>
<person name="Eddy S.R."/>
<person name="Marra M.A."/>
<person name="Ovcharenko I."/>
<person name="Furey T.S."/>
<person name="Miller W."/>
<person name="Eichler E.E."/>
<person name="Bork P."/>
<person name="Suyama M."/>
<person name="Torrents D."/>
<person name="Waterston R.H."/>
<person name="Wilson R.K."/>
</authorList>
<dbReference type="PubMed" id="15815621"/>
<dbReference type="DOI" id="10.1038/nature03466"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="3">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 301-2002 (ISOFORM 2)</scope>
<source>
<tissue>Adipose tissue</tissue>
<tissue>Placenta</tissue>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="2003" name="Cancer Lett." volume="197" first="63" last="68">
<title>Neuroblastoma oligo-capping cDNA project: toward the understanding of the genesis and biology of neuroblastoma.</title>
<authorList>
<person name="Ohira M."/>
<person name="Morohashi A."/>
<person name="Nakamura Y."/>
<person name="Isogai E."/>
<person name="Furuya K."/>
<person name="Hamano S."/>
<person name="Machida T."/>
<person name="Aoyama M."/>
<person name="Fukumura M."/>
<person name="Miyazaki K."/>
<person name="Suzuki Y."/>
<person name="Sugano S."/>
<person name="Hirato J."/>
<person name="Nakagawara A."/>
</authorList>
<dbReference type="PubMed" id="12880961"/>
<dbReference type="DOI" id="10.1016/s0304-3835(03)00085-5"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 791-2002 (ISOFORM 3)</scope>
<source>
<tissue>Neuroblastoma</tissue>
</source>
</reference>
<reference key="5">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1198-2002 (ISOFORM 1)</scope>
<scope>VARIANT VAL-1762</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2000" name="DNA Res." volume="7" first="273" last="281">
<title>Prediction of the coding sequences of unidentified human genes. XVIII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.</title>
<authorList>
<person name="Nagase T."/>
<person name="Kikuno R."/>
<person name="Nakayama M."/>
<person name="Hirosawa M."/>
<person name="Ohara O."/>
</authorList>
<dbReference type="PubMed" id="10997877"/>
<dbReference type="DOI" id="10.1093/dnares/7.4.271"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1319-2002 (ISOFORM 1)</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="7">
<citation type="journal article" date="2003" name="Leukemia" volume="17" first="637" last="641">
<title>TET1, a member of a novel protein family, is fused to MLL in acute myeloid leukemia containing the t(10;11)(q22;q23).</title>
<authorList>
<person name="Lorsbach R.B."/>
<person name="Moore J."/>
<person name="Mathew S."/>
<person name="Raimondi S.C."/>
<person name="Mukatira S.T."/>
<person name="Downing J.R."/>
</authorList>
<dbReference type="PubMed" id="12646957"/>
<dbReference type="DOI" id="10.1038/sj.leu.2402834"/>
</citation>
<scope>IDENTIFICATION</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2004" name="Int. J. Oncol." volume="25" first="1193" last="1199">
<title>Identification and characterization of human CXXC10 gene in silico.</title>
<authorList>
<person name="Katoh M."/>
<person name="Katoh M."/>
</authorList>
<dbReference type="PubMed" id="15375572"/>
</citation>
<scope>IDENTIFICATION</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="10">
<citation type="journal article" date="2009" name="Anal. Chem." volume="81" first="4493" last="4501">
<title>Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.</title>
<authorList>
<person name="Gauci S."/>
<person name="Helbig A.O."/>
<person name="Slijper M."/>
<person name="Krijgsveld J."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="19413330"/>
<dbReference type="DOI" id="10.1021/ac9004309"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2009" name="Blood" volume="114" first="144" last="147">
<title>Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies.</title>
<authorList>
<person name="Abdel-Wahab O."/>
<person name="Mullally A."/>
<person name="Hedvat C."/>
<person name="Garcia-Manero G."/>
<person name="Patel J."/>
<person name="Wadleigh M."/>
<person name="Malinge S."/>
<person name="Yao J."/>
<person name="Kilpivaara O."/>
<person name="Bhat R."/>
<person name="Huberman K."/>
<person name="Thomas S."/>
<person name="Dolgalev I."/>
<person name="Heguy A."/>
<person name="Paietta E."/>
<person name="Le Beau M.M."/>
<person name="Beran M."/>
<person name="Tallman M.S."/>
<person name="Ebert B.L."/>
<person name="Kantarjian H.M."/>
<person name="Stone R.M."/>
<person name="Gilliland D.G."/>
<person name="Crispino J.D."/>
<person name="Levine R.L."/>
</authorList>
<dbReference type="PubMed" id="19420352"/>
<dbReference type="DOI" id="10.1182/blood-2009-03-210039"/>
</citation>
<scope>INVOLVEMENT IN MYELOID MALIGNANCIES</scope>
<scope>VARIANTS PHE-34; ASN-145; HIS-174; SER-312; PHE-460; GLY-666; HIS-867; SER-941; VAL-1073; PRO-1084; TYR-1135; CYS-1204; TRP-1214; VAL-1242; SER-1245; CYS-1261; HIS-1261; PHE-1417; LEU-1718; SER-1723; ASP-1757; ARG-1811; LEU-1828; THR-1873; ARG-1881; ALA-1900; VAL-1919; HIS-1926; SER-1941; HIS-1966; MET-1974 AND LYS-2000</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2009" name="Blood" volume="113" first="6403" last="6410">
<title>Loss of heterozygosity 4q24 and TET2 mutations associated with myelodysplastic/myeloproliferative neoplasms.</title>
<authorList>
<person name="Jankowska A.M."/>
<person name="Szpurka H."/>
<person name="Tiu R.V."/>
<person name="Makishima H."/>
<person name="Afable M."/>
<person name="Huh J."/>
<person name="O'Keefe C.L."/>
<person name="Ganetzky R."/>
<person name="McDevitt M.A."/>
<person name="Maciejewski J.P."/>
</authorList>
<dbReference type="PubMed" id="19372255"/>
<dbReference type="DOI" id="10.1182/blood-2009-02-205690"/>
</citation>
<scope>INVOLVEMENT IN MDS</scope>
<scope>INVOLVEMENT IN MYELOPROLIFERATIVE DISORDERS</scope>
<scope>VARIANTS THR-308; LEU-399; THR-817; HIS-867; PRO-1084; THR-1167; LEU-1287; ASN-1299; GLY-1302; GLY-1318; LEU-1718; THR-1873 AND ASP-1913</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2009" name="Leukemia" volume="23" first="900" last="904">
<title>Frequent TET2 mutations in systemic mastocytosis: clinical, KITD816V and FIP1L1-PDGFRA correlates.</title>
<authorList>
<person name="Tefferi A."/>
<person name="Levine R.L."/>
<person name="Lim K.H."/>
<person name="Abdel-Wahab O."/>
<person name="Lasho T.L."/>
<person name="Patel J."/>
<person name="Finke C.M."/>
<person name="Mullally A."/>
<person name="Li C.Y."/>
<person name="Pardanani A."/>
<person name="Gilliland D.G."/>
</authorList>
<dbReference type="PubMed" id="19262599"/>
<dbReference type="DOI" id="10.1038/leu.2009.37"/>
</citation>
<scope>INVOLVEMENT IN SYSTEMIC MASTOCYTOSIS</scope>
<scope>VARIANT ARG-1881</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2009" name="Leukemia" volume="23" first="905" last="911">
<title>TET2 mutations and their clinical correlates in polycythemia vera, essential thrombocythemia and myelofibrosis.</title>
<authorList>
<person name="Tefferi A."/>
<person name="Pardanani A."/>
<person name="Lim K.H."/>
<person name="Abdel-Wahab O."/>
<person name="Lasho T.L."/>
<person name="Patel J."/>
<person name="Gangat N."/>
<person name="Finke C.M."/>
<person name="Schwager S."/>
<person name="Mullally A."/>
<person name="Li C.-Y."/>
<person name="Hanson C.A."/>
<person name="Mesa R."/>
<person name="Bernard O."/>
<person name="Delhommeau F."/>
<person name="Vainchenker W."/>
<person name="Gilliland D.G."/>
<person name="Levine R.L."/>
</authorList>
<dbReference type="PubMed" id="19262601"/>
<dbReference type="DOI" id="10.1038/leu.2009.47"/>
</citation>
<scope>INVOLVEMENT IN MYELOPROLIFERATIVE DISORDERS</scope>
<scope>VARIANTS ARG-1242 AND THR-1873</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2009" name="Nat. Genet." volume="41" first="838" last="842">
<title>Acquired mutations in TET2 are common in myelodysplastic syndromes.</title>
<authorList>
<person name="Langemeijer S.M.C."/>
<person name="Kuiper R.P."/>
<person name="Berends M."/>
<person name="Knops R."/>
<person name="Aslanyan M.G."/>
<person name="Massop M."/>
<person name="Stevens-Linders E."/>
<person name="van Hoogen P."/>
<person name="van Kessel A.G."/>
<person name="Raymakers R.A.P."/>
<person name="Kamping E.J."/>
<person name="Verhoef G.E."/>
<person name="Verburgh E."/>
<person name="Hagemeijer A."/>
<person name="Vandenberghe P."/>
<person name="de Witte T."/>
<person name="van der Reijden B.A."/>
<person name="Jansen J.H."/>
</authorList>
<dbReference type="PubMed" id="19483684"/>
<dbReference type="DOI" id="10.1038/ng.391"/>
</citation>
<scope>INVOLVEMENT IN MDS</scope>
<scope>FUNCTION</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>VARIANTS ARG-29; PHE-34; HIS-123; MET-218; ASP-355; LEU-363; ARG-429; HIS-867; ARG-924; ARG-949; PRO-1084; TRP-1214; LEU-1261; PHE-1285 DEL; ARG-1291; TRP-1396; ARG-1398; ILE-1701; TRP-1721; SER-1723; VAL-1762; ARG-1778; THR-1873; ARG-1875; GLN-1881; SER-1896; 1911-LYS--LEU-1916 DEL; ASP-1913 AND LEU-1962</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2009" name="Sci. Signal." volume="2" first="RA46" last="RA46">
<title>Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.</title>
<authorList>
<person name="Mayya V."/>
<person name="Lundgren D.H."/>
<person name="Hwang S.-I."/>
<person name="Rezaul K."/>
<person name="Wu L."/>
<person name="Eng J.K."/>
<person name="Rodionov V."/>
<person name="Han D.K."/>
</authorList>
<dbReference type="PubMed" id="19690332"/>
<dbReference type="DOI" id="10.1126/scisignal.2000007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-99 AND SER-1107</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="17">
<citation type="journal article" date="2010" name="Nature" volume="468" first="839" last="843">
<title>Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2.</title>
<authorList>
<person name="Ko M."/>
<person name="Huang Y."/>
<person name="Jankowska A.M."/>
<person name="Pape U.J."/>
<person name="Tahiliani M."/>
<person name="Bandukwala H.S."/>
<person name="An J."/>
<person name="Lamperti E.D."/>
<person name="Koh K.P."/>
<person name="Ganetzky R."/>
<person name="Liu X.S."/>
<person name="Aravind L."/>
<person name="Agarwal S."/>
<person name="Maciejewski J.P."/>
<person name="Rao A."/>
</authorList>
<dbReference type="PubMed" id="21057493"/>
<dbReference type="DOI" id="10.1038/nature09586"/>
</citation>
<scope>FUNCTION</scope>
<scope>INVOLVEMENT IN MDS</scope>
<scope>INVOLVEMENT IN MYELOPROLIFERATIVE DISORDERS</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2011" name="Science" volume="333" first="1303" last="1307">
<title>Tet-mediated formation of 5-carboxylcytosine and its excision by TDG in mammalian DNA.</title>
<authorList>
<person name="He Y.F."/>
<person name="Li B.Z."/>
<person name="Li Z."/>
<person name="Liu P."/>
<person name="Wang Y."/>
<person name="Tang Q."/>
<person name="Ding J."/>
<person name="Jia Y."/>
<person name="Chen Z."/>
<person name="Li L."/>
<person name="Sun Y."/>
<person name="Li X."/>
<person name="Dai Q."/>
<person name="Song C.X."/>
<person name="Zhang K."/>
<person name="He C."/>
<person name="Xu G.L."/>
</authorList>
<dbReference type="PubMed" id="21817016"/>
<dbReference type="DOI" id="10.1126/science.1210944"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2013" name="EMBO J." volume="32" first="645" last="655">
<title>TET2 and TET3 regulate GlcNAcylation and H3K4 methylation through OGT and SET1/COMPASS.</title>
<authorList>
<person name="Deplus R."/>
<person name="Delatte B."/>
<person name="Schwinn M.K."/>
<person name="Defrance M."/>
<person name="Mendez J."/>
<person name="Murphy N."/>
<person name="Dawson M.A."/>
<person name="Volkmar M."/>
<person name="Putmans P."/>
<person name="Calonne E."/>
<person name="Shih A.H."/>
<person name="Levine R.L."/>
<person name="Bernard O."/>
<person name="Mercher T."/>
<person name="Solary E."/>
<person name="Urh M."/>
<person name="Daniels D.L."/>
<person name="Fuks F."/>
</authorList>
<dbReference type="PubMed" id="23353889"/>
<dbReference type="DOI" id="10.1038/emboj.2012.357"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH HCFC1 AND OGT</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-75; SER-99; SER-1107 AND SER-1109</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="21">
<citation type="journal article" date="2013" name="Nature" volume="493" first="561" last="564">
<title>TET2 promotes histone O-GlcNAcylation during gene transcription.</title>
<authorList>
<person name="Chen Q."/>
<person name="Chen Y."/>
<person name="Bian C."/>
<person name="Fujiki R."/>
<person name="Yu X."/>
</authorList>
<dbReference type="PubMed" id="23222540"/>
<dbReference type="DOI" id="10.1038/nature11742"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH OGT</scope>
<scope>MUTAGENESIS OF HIS-1382 AND ASP-1384</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2014" name="Mol. Cell. Proteomics" volume="13" first="372" last="387">
<title>Immunoaffinity enrichment and mass spectrometry analysis of protein methylation.</title>
<authorList>
<person name="Guo A."/>
<person name="Gu H."/>
<person name="Zhou J."/>
<person name="Mulhern D."/>
<person name="Wang Y."/>
<person name="Lee K.A."/>
<person name="Yang V."/>
<person name="Aguiar M."/>
<person name="Kornhauser J."/>
<person name="Jia X."/>
<person name="Ren J."/>
<person name="Beausoleil S.A."/>
<person name="Silva J.C."/>
<person name="Vemulapalli V."/>
<person name="Bedford M.T."/>
<person name="Comb M.J."/>
</authorList>
<dbReference type="PubMed" id="24129315"/>
<dbReference type="DOI" id="10.1074/mcp.o113.027870"/>
</citation>
<scope>METHYLATION [LARGE SCALE ANALYSIS] AT ARG-1682</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Colon carcinoma</tissue>
</source>
</reference>
<reference key="23">
<citation type="journal article" date="2013" name="Cell" volume="155" first="1545" last="1555">
<title>Crystal structure of TET2-DNA complex: insight into TET-mediated 5mC oxidation.</title>
<authorList>
<person name="Hu L."/>
<person name="Li Z."/>
<person name="Cheng J."/>
<person name="Rao Q."/>
<person name="Gong W."/>
<person name="Liu M."/>
<person name="Shi Y.G."/>
<person name="Zhu J."/>
<person name="Wang P."/>
<person name="Xu Y."/>
</authorList>
<dbReference type="PubMed" id="24315485"/>
<dbReference type="DOI" id="10.1016/j.cell.2013.11.020"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.03 ANGSTROMS) OF 1129-1480 AND 1844-1936 IN COMPLEX WITH DNA; IRON; N-OXALYOLGLYCINE AND ZINC</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>FUNCTION</scope>
<scope>CHARACTERIZATION OF VARIANTS ARG-1291; GLU-1299; MET-1896 AND PHE-1898</scope>
<scope>MUTAGENESIS OF ARG-1261; ARG-1262; SER-1290; 1291-TRP--ASN-1296; 1293-MET-TYR-1294; TYR-1295; SER-1303; HIS-1382; ASP-1384; ASN-1387; TYR-1902 AND HIS-1904</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2009" name="N. Engl. J. Med." volume="360" first="2289" last="2301">
<title>Mutation in TET2 in myeloid cancers.</title>
<authorList>
<person name="Delhommeau F."/>
<person name="Dupont S."/>
<person name="Della Valle V."/>
<person name="James C."/>
<person name="Trannoy S."/>
<person name="Masse A."/>
<person name="Kosmider O."/>
<person name="Le Couedic J.-P."/>
<person name="Robert F."/>
<person name="Alberdi A."/>
<person name="Lecluse Y."/>
<person name="Plo I."/>
<person name="Dreyfus F.J."/>
<person name="Marzac C."/>
<person name="Casadevall N."/>
<person name="Lacombe C."/>
<person name="Romana S.P."/>
<person name="Dessen P."/>
<person name="Soulier J."/>
<person name="Viguie F."/>
<person name="Fontenay M."/>
<person name="Vainchenker W."/>
<person name="Bernard O.A."/>
</authorList>
<dbReference type="PubMed" id="19474426"/>
<dbReference type="DOI" id="10.1056/nejmoa0810069"/>
</citation>
<scope>VARIANTS VAL-1175; 1237-PRO--SER-1239 DEL; GLU-1299; GLY-1302; TRP-1869; PRO-1872; THR-1873; MET-1896 AND PHE-1898</scope>
</reference>
<comment type="function">
<text evidence="16 17 18 19 20 21">Dioxygenase that catalyzes the conversion of the modified genomic base 5-methylcytosine (5mC) into 5-hydroxymethylcytosine (5hmC) and plays a key role in active DNA demethylation. Has a preference for 5-hydroxymethylcytosine in CpG motifs. Also mediates subsequent conversion of 5hmC into 5-formylcytosine (5fC), and conversion of 5fC to 5-carboxylcytosine (5caC). Conversion of 5mC into 5hmC, 5fC and 5caC probably constitutes the first step in cytosine demethylation. Methylation at the C5 position of cytosine bases is an epigenetic modification of the mammalian genome which plays an important role in transcriptional regulation. In addition to its role in DNA demethylation, also involved in the recruitment of the O-GlcNAc transferase OGT to CpG-rich transcription start sites of active genes, thereby promoting histone H2B GlcNAcylation by OGT.</text>
</comment>
<comment type="catalytic activity">
<reaction evidence="21">
<text>2-oxoglutarate + a 5-methyl-2'-deoxycytidine in DNA + O2 = a 5-hydroxymethyl-2'-deoxycytidine in DNA + CO2 + succinate</text>
<dbReference type="Rhea" id="RHEA:52636"/>
<dbReference type="Rhea" id="RHEA-COMP:11370"/>
<dbReference type="Rhea" id="RHEA-COMP:13315"/>
<dbReference type="ChEBI" id="CHEBI:15379"/>
<dbReference type="ChEBI" id="CHEBI:16526"/>
<dbReference type="ChEBI" id="CHEBI:16810"/>
<dbReference type="ChEBI" id="CHEBI:30031"/>
<dbReference type="ChEBI" id="CHEBI:85454"/>
<dbReference type="ChEBI" id="CHEBI:136731"/>
<dbReference type="EC" id="1.14.11.n2"/>
</reaction>
</comment>
<comment type="cofactor">
<cofactor evidence="21">
<name>Fe(2+)</name>
<dbReference type="ChEBI" id="CHEBI:29033"/>
</cofactor>
<text evidence="21">Binds 1 Fe(2+) ion per subunit.</text>
</comment>
<comment type="cofactor">
<cofactor evidence="21">
<name>Zn(2+)</name>
<dbReference type="ChEBI" id="CHEBI:29105"/>
</cofactor>
<text evidence="21">Binds 3 zinc ions per subunit. The zinc ions have a structural role (PubMed:24315485).</text>
</comment>
<comment type="subunit">
<text evidence="19 20 21">Interacts with HCFC1 and OGT.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-310727">
<id>Q6N021</id>
</interactant>
<interactant intactId="EBI-539828">
<id>O15294</id>
<label>OGT</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-310727">
<id>Q6N021</id>
</interactant>
<interactant intactId="EBI-295890">
<id>P29590</id>
<label>PML</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-310727">
<id>Q6N021</id>
</interactant>
<interactant intactId="EBI-2320534">
<id>P19544</id>
<label>WT1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>9</experiments>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>Q6N021-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>Q6N021-2</id>
<name>2</name>
<sequence type="described" ref="VSP_032283 VSP_032284"/>
</isoform>
<isoform>
<id>Q6N021-3</id>
<name>3</name>
<sequence type="described" ref="VSP_032282 VSP_032285"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="8 16">Broadly expressed. Highly expressed in hematopoietic cells; highest expression observed in granulocytes. Expression is reduced in granulocytes from peripheral blood of patients affected by myelodysplastic syndromes.</text>
</comment>
<comment type="PTM">
<text evidence="20">May be glycosylated. It is unclear whether interaction with OGT leads to GlcNAcylation. According to a report, it is not GlcNAcylated by OGT (PubMed:23353889). In contrast, another group reports GlcNAcylation by OGT in mouse ortholog.</text>
</comment>
<comment type="disease">
<text>TET2 is frequently mutated in myeloproliferative disorders (MPD). These constitute a heterogeneous group of disorders, also known as myeloproliferative diseases or myeloproliferative neoplasms (MPN), characterized by cellular proliferation of one or more hematologic cell lines in the peripheral blood, distinct from acute leukemia. Included diseases are: essential thrombocythemia, polycythemia vera, primary myelofibrosis (chronic idiopathic myelofibrosis). Bone marrow samples from patients display uniformly low levels of hmC in genomic DNA compared to bone marrow samples from healthy controls as well as hypomethylation relative to controls at the majority of differentially methylated CpG sites.</text>
</comment>
<comment type="disease">
<disease id="DI-02712">
<name>Polycythemia vera</name>
<acronym>PV</acronym>
<description>A myeloproliferative disorder characterized by abnormal proliferation of all hematopoietic bone marrow elements, erythroid hyperplasia, an absolute increase in total blood volume, but also by myeloid leukocytosis, thrombocytosis and splenomegaly.</description>
<dbReference type="MIM" id="263300"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease">
<text>TET2 is frequently mutated in systemic mastocytosis; also known as systemic mast cell disease. A condition with features in common with myeloproliferative diseases. It is a clonal disorder of the mast cell and its precursor cells. The clinical symptoms and signs of systemic mastocytosis are due to accumulation of clonally derived mast cells in different tissues, including bone marrow, skin, the gastrointestinal tract, the liver, and the spleen.</text>
</comment>
<comment type="disease" evidence="13 16 17">
<disease id="DI-03291">
<name>Myelodysplastic syndrome</name>
<acronym>MDS</acronym>
<description>A heterogeneous group of closely related clonal hematopoietic disorders. All are characterized by a hypercellular or hypocellular bone marrow with impaired morphology and maturation, dysplasia of the myeloid, megakaryocytic and/or erythroid lineages, and peripheral blood cytopenias resulting from ineffective blood cell production. Included diseases are: refractory anemia (RA), refractory anemia with ringed sideroblasts (RARS), refractory anemia with excess blasts (RAEB), refractory cytopenia with multilineage dysplasia and ringed sideroblasts (RCMD-RS); chronic myelomonocytic leukemia (CMML) is a myelodysplastic/myeloproliferative disease. MDS is considered a premalignant condition in a subgroup of patients that often progresses to acute myeloid leukemia (AML).</description>
<dbReference type="MIM" id="614286"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry. Bone marrow samples from patients display uniformly low levels of hmC in genomic DNA compared to bone marrow samples from healthy controls as well as hypomethylation relative to controls at the majority of differentially methylated CpG sites.</text>
</comment>
<comment type="miscellaneous">
<molecule>Isoform 3</molecule>
<text evidence="25">May be produced at very low levels due to a premature stop codon in the mRNA, leading to nonsense-mediated mRNA decay.</text>
</comment>
<comment type="similarity">
<text evidence="25">Belongs to the TET family.</text>
</comment>
<comment type="caution">
<text evidence="26">Subsequent steps in cytosine demethylation are subject to discussion. According to a first model cytosine demethylation occurs through deamination of 5hmC into 5-hydroxymethyluracil (5hmU) and subsequent replacement by unmethylated cytosine by the base excision repair system. According to another model, cytosine demethylation is rather mediated via conversion of 5hmC into 5fC and 5caC, followed by excision by TDG (PubMed:21817016).</text>
</comment>
<comment type="sequence caution" evidence="25">
<conflict type="erroneous termination">
<sequence resource="EMBL-CDS" id="BAA90898" version="1"/>
</conflict>
<text>Truncated C-terminus.</text>
</comment>
<comment type="sequence caution" evidence="25">
<conflict type="frameshift">
<sequence resource="EMBL-CDS" id="BAA90898" version="1"/>
</conflict>
</comment>
<comment type="sequence caution" evidence="25">
<conflict type="miscellaneous discrepancy">
<sequence resource="EMBL-CDS" id="BAA90898" version="1"/>
</conflict>
<text>Contaminating sequence. Potential poly-A sequence.</text>
</comment>
<comment type="sequence caution" evidence="25">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="BAB55391" version="1"/>
</conflict>
<text>Truncated N-terminus.</text>
</comment>
<dbReference type="EC" id="1.14.11.n2" evidence="21"/>
<dbReference type="EMBL" id="BX640738">
<property type="protein sequence ID" value="CAE45851.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AC004069">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AC026029">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AK000039">
<property type="protein sequence ID" value="BAA90898.1"/>
<property type="status" value="ALT_SEQ"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK027819">
<property type="protein sequence ID" value="BAB55391.1"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB075496">
<property type="protein sequence ID" value="BAE45750.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC110509">
<property type="protein sequence ID" value="AAI10510.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC110510">
<property type="protein sequence ID" value="AAI10511.2"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB046766">
<property type="protein sequence ID" value="BAB13372.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS3666.1">
<molecule id="Q6N021-2"/>
</dbReference>
<dbReference type="CCDS" id="CCDS47120.1">
<molecule id="Q6N021-1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001120680.1">
<molecule id="Q6N021-1"/>
<property type="nucleotide sequence ID" value="NM_001127208.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_060098.3">
<molecule id="Q6N021-2"/>
<property type="nucleotide sequence ID" value="NM_017628.4"/>
</dbReference>
<dbReference type="RefSeq" id="XP_005263139.1">
<molecule id="Q6N021-1"/>
<property type="nucleotide sequence ID" value="XM_005263082.2"/>
</dbReference>
<dbReference type="PDB" id="4NM6">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.03"/>
<property type="chains" value="A=1129-1480, A=1844-1936"/>
</dbReference>
<dbReference type="PDB" id="5D9Y">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.97"/>
<property type="chains" value="A=1129-1480, A=1844-1936"/>
</dbReference>
<dbReference type="PDB" id="5DEU">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.80"/>
<property type="chains" value="A=1129-1480, A=1844-1935"/>
</dbReference>
<dbReference type="PDBsum" id="4NM6"/>
<dbReference type="PDBsum" id="5D9Y"/>
<dbReference type="PDBsum" id="5DEU"/>
<dbReference type="SMR" id="Q6N021"/>
<dbReference type="BioGRID" id="120151">
<property type="interactions" value="78"/>
</dbReference>
<dbReference type="IntAct" id="Q6N021">
<property type="interactions" value="15"/>
</dbReference>
<dbReference type="MINT" id="Q6N021"/>
<dbReference type="STRING" id="9606.ENSP00000442788"/>
<dbReference type="iPTMnet" id="Q6N021"/>
<dbReference type="PhosphoSitePlus" id="Q6N021"/>
<dbReference type="BioMuta" id="TET2"/>
<dbReference type="DMDM" id="239938839"/>
<dbReference type="EPD" id="Q6N021"/>
<dbReference type="jPOST" id="Q6N021"/>
<dbReference type="MassIVE" id="Q6N021"/>
<dbReference type="MaxQB" id="Q6N021"/>
<dbReference type="PaxDb" id="Q6N021"/>
<dbReference type="PeptideAtlas" id="Q6N021"/>
<dbReference type="PRIDE" id="Q6N021"/>
<dbReference type="ProteomicsDB" id="66598">
<molecule id="Q6N021-1"/>
</dbReference>
<dbReference type="ProteomicsDB" id="66599">
<molecule id="Q6N021-2"/>
</dbReference>
<dbReference type="ProteomicsDB" id="66600">
<molecule id="Q6N021-3"/>
</dbReference>
<dbReference type="Antibodypedia" id="45118">
<property type="antibodies" value="442 antibodies"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000265149">
<molecule id="Q6N021-3"/>
<property type="protein sequence ID" value="ENSP00000265149"/>
<property type="gene ID" value="ENSG00000168769"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000305737">
<molecule id="Q6N021-2"/>
<property type="protein sequence ID" value="ENSP00000306705"/>
<property type="gene ID" value="ENSG00000168769"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000380013">
<molecule id="Q6N021-1"/>
<property type="protein sequence ID" value="ENSP00000369351"/>
<property type="gene ID" value="ENSG00000168769"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000540549">
<molecule id="Q6N021-1"/>
<property type="protein sequence ID" value="ENSP00000442788"/>
<property type="gene ID" value="ENSG00000168769"/>
</dbReference>
<dbReference type="GeneID" id="54790"/>
<dbReference type="KEGG" id="hsa:54790"/>
<dbReference type="UCSC" id="uc003hxj.3">
<molecule id="Q6N021-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="54790"/>
<dbReference type="DisGeNET" id="54790"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000168769.12"/>
<dbReference type="GeneCards" id="TET2"/>
<dbReference type="HGNC" id="HGNC:25941">
<property type="gene designation" value="TET2"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000168769">
<property type="expression patterns" value="Low tissue specificity"/>
</dbReference>
<dbReference type="MalaCards" id="TET2"/>
<dbReference type="MIM" id="263300">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="612839">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="614286">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q6N021"/>
<dbReference type="OpenTargets" id="ENSG00000168769"/>
<dbReference type="Orphanet" id="75564">
<property type="disease" value="Acquired idiopathic sideroblastic anemia"/>
</dbReference>
<dbReference type="Orphanet" id="86845">
<property type="disease" value="Acute myeloid leukaemia with myelodysplasia-related features"/>
</dbReference>
<dbReference type="Orphanet" id="98850">
<property type="disease" value="Aggressive systemic mastocytosis"/>
</dbReference>
<dbReference type="Orphanet" id="3318">
<property type="disease" value="Essential thrombocythemia"/>
</dbReference>
<dbReference type="Orphanet" id="729">
<property type="disease" value="Polycythemia vera"/>
</dbReference>
<dbReference type="Orphanet" id="824">
<property type="disease" value="Primary myelofibrosis"/>
</dbReference>
<dbReference type="Orphanet" id="98826">
<property type="disease" value="Refractory anemia"/>
</dbReference>
<dbReference type="Orphanet" id="86839">
<property type="disease" value="Refractory anemia with excess blasts"/>
</dbReference>
<dbReference type="Orphanet" id="98849">
<property type="disease" value="Systemic mastocytosis with associated hematologic neoplasm"/>
</dbReference>
<dbReference type="PharmGKB" id="PA162405634"/>
<dbReference type="eggNOG" id="ENOG502QURD">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00940000160003"/>
<dbReference type="HOGENOM" id="CLU_274735_0_0_1"/>
<dbReference type="InParanoid" id="Q6N021"/>
<dbReference type="OrthoDB" id="29059at2759"/>
<dbReference type="PhylomeDB" id="Q6N021"/>
<dbReference type="TreeFam" id="TF337563"/>
<dbReference type="PathwayCommons" id="Q6N021"/>
<dbReference type="Reactome" id="R-HSA-5221030">
<property type="pathway name" value="TET1,2,3 and TDG demethylate DNA"/>
</dbReference>
<dbReference type="SIGNOR" id="Q6N021"/>
<dbReference type="BioGRID-ORCS" id="54790">
<property type="hits" value="4 hits in 875 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="TET2">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="GenomeRNAi" id="54790"/>
<dbReference type="Pharos" id="Q6N021">
<property type="development level" value="Tbio"/>
</dbReference>
<dbReference type="PRO" id="PR:Q6N021"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 4"/>
</dbReference>
<dbReference type="RNAct" id="Q6N021">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000168769">
<property type="expression patterns" value="Expressed in blood and 208 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="Q6N021">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q6N021">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0003677">
<property type="term" value="F:DNA binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0008198">
<property type="term" value="F:ferrous iron binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0070579">
<property type="term" value="F:methylcytosine dioxygenase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008270">
<property type="term" value="F:zinc ion binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006211">
<property type="term" value="P:5-methylcytosine catabolic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007049">
<property type="term" value="P:cell cycle"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0080111">
<property type="term" value="P:DNA demethylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0080182">
<property type="term" value="P:histone H3-K4 trimethylation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030099">
<property type="term" value="P:myeloid cell differentiation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0070989">
<property type="term" value="P:oxidative demethylation"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0045944">
<property type="term" value="P:positive regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006493">
<property type="term" value="P:protein O-linked glycosylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0014070">
<property type="term" value="P:response to organic cyclic compound"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="InterPro" id="IPR024779">
<property type="entry name" value="2OGFeDO_noxygenase_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR040175">
<property type="entry name" value="TET1/2/3"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR23358">
<property type="entry name" value="PTHR23358"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF12851">
<property type="entry name" value="Tet_JBP"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM01333">
<property type="entry name" value="Tet_JBP"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0131">Cell cycle</keyword>
<keyword id="KW-0156">Chromatin regulator</keyword>
<keyword id="KW-0223">Dioxygenase</keyword>
<keyword id="KW-0238">DNA-binding</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0408">Iron</keyword>
<keyword id="KW-0479">Metal-binding</keyword>
<keyword id="KW-0488">Methylation</keyword>
<keyword id="KW-0560">Oxidoreductase</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0043">Tumor suppressor</keyword>
<keyword id="KW-0862">Zinc</keyword>
<feature type="chain" description="Methylcytosine dioxygenase TET2" id="PRO_0000324588">
<location>
<begin position="1"/>
<end position="2002"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with DNA">
<location>
<begin position="1290"/>
<end position="1303"/>
</location>
</feature>
<feature type="region of interest" description="2-oxoglutarate binding" evidence="21">
<location>
<begin position="1896"/>
<end position="1898"/>
</location>
</feature>
<feature type="region of interest" description="Substrate binding" evidence="21">
<location>
<begin position="1902"/>
<end position="1904"/>
</location>
</feature>
<feature type="compositionally biased region" description="Pro-rich">
<location>
<begin position="398"/>
<end position="419"/>
</location>
</feature>
<feature type="compositionally biased region" description="Gln-rich">
<location>
<begin position="591"/>
<end position="969"/>
</location>
</feature>
<feature type="compositionally biased region" description="Gln-rich">
<location>
<begin position="1523"/>
<end position="1553"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc 1" evidence="21">
<location>
<position position="1133"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc 1" evidence="21">
<location>
<position position="1135"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc 2" evidence="21">
<location>
<position position="1193"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc 1; via pros nitrogen" evidence="21">
<location>
<position position="1219"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc 1" evidence="21">
<location>
<position position="1221"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc 2" evidence="21">
<location>
<position position="1271"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc 2" evidence="21">
<location>
<position position="1273"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc 3" evidence="21">
<location>
<position position="1289"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc 3" evidence="21">
<location>
<position position="1298"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc 3" evidence="21">
<location>
<position position="1358"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc 2; via tele nitrogen" evidence="21">
<location>
<position position="1380"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Iron; catalytic" evidence="21">
<location>
<position position="1382"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Iron; catalytic" evidence="21">
<location>
<position position="1384"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Iron; catalytic" evidence="21">
<location>
<position position="1881"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc 3; via pros nitrogen" evidence="21">
<location>
<position position="1912"/>
</location>
</feature>
<feature type="binding site" description="2-oxoglutarate" evidence="21">
<location>
<position position="1261"/>
</location>
</feature>
<feature type="binding site" description="2-oxoglutarate" evidence="21">
<location>
<position position="1374"/>
</location>
</feature>
<feature type="binding site" description="Substrate" evidence="21">
<location>
<position position="1387"/>
</location>
</feature>
<feature type="binding site" description="2-oxoglutarate" evidence="21">
<location>
<position position="1416"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="7">
<location>
<position position="15"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="5">
<location>
<position position="75"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="4 5">
<location>
<position position="99"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="4 5">
<location>
<position position="1107"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="5">
<location>
<position position="1109"/>
</location>
</feature>
<feature type="modified residue" description="Asymmetric dimethylarginine" evidence="6">
<location>
<position position="1682"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_032282" evidence="22">
<original>EQIIEKDEGPFYTHLGAGPNVAAIREIMEERFGQKGKAIRIERVIYTGKEGKSSQGCP</original>
<variation>GLDRRVKLLGLKESSILVKKAKVLRDVLLLSGWFAEAAVKRSYCVWCGSELATPVRLQ</variation>
<location>
<begin position="1137"/>
<end position="1194"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_032283" evidence="23 24">
<original>EQIIEKDEGPFYTHLGAGPNVAAIREIME</original>
<variation>GKCQKCTETHGVYPELANLSSDMGFSFFF</variation>
<location>
<begin position="1137"/>
<end position="1165"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_032284" evidence="23 24">
<location>
<begin position="1166"/>
<end position="2002"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_032285" evidence="22">
<location>
<begin position="1195"/>
<end position="2002"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs12498609." id="VAR_039841" evidence="16">
<original>P</original>
<variation>R</variation>
<location>
<position position="29"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs111948941." id="VAR_058171" evidence="14 16">
<original>L</original>
<variation>F</variation>
<location>
<position position="34"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs773565437." id="VAR_058130" evidence="16">
<original>R</original>
<variation>H</variation>
<location>
<position position="123"/>
</location>
</feature>
<feature type="sequence variant" description="In a chronic myelomonocytic leukemia sample; somatic mutation; dbSNP:rs114619974." id="VAR_058172" evidence="14">
<original>S</original>
<variation>N</variation>
<location>
<position position="145"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs146031219." id="VAR_058173" evidence="14">
<original>P</original>
<variation>H</variation>
<location>
<position position="174"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs6843141." id="VAR_039842" evidence="10 16">
<original>V</original>
<variation>M</variation>
<location>
<position position="218"/>
</location>
</feature>
<feature type="sequence variant" description="In chronic myelomonocytic leukemia and acute myeloid leukemia samples; dbSNP:rs569067880." id="VAR_058131" evidence="13">
<original>A</original>
<variation>T</variation>
<location>
<position position="308"/>
</location>
</feature>
<feature type="sequence variant" description="In an acute myeloid leukemia sample; somatic mutation." id="VAR_058174" evidence="14">
<original>N</original>
<variation>S</variation>
<location>
<position position="312"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs61744960." id="VAR_058132" evidence="16">
<original>G</original>
<variation>D</variation>
<location>
<position position="355"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs17253672." id="VAR_039843" evidence="16">
<original>P</original>
<variation>L</variation>
<location>
<position position="363"/>
</location>
</feature>
<feature type="sequence variant" description="In myelodysplastic/myeloproliferative disorders; a patient positive for mutation F-617 in JAK2." id="VAR_058133" evidence="13">
<original>P</original>
<variation>L</variation>
<location>
<position position="399"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs201642693." id="VAR_058134" evidence="16">
<original>G</original>
<variation>R</variation>
<location>
<position position="429"/>
</location>
</feature>
<feature type="sequence variant" description="In a chronic myelomonocytic leukemia sample; somatic mutation; dbSNP:rs376570662." id="VAR_058175" evidence="14">
<original>S</original>
<variation>F</variation>
<location>
<position position="460"/>
</location>
</feature>
<feature type="sequence variant" description="In a chronic myelomonocytic leukemia sample; somatic mutation." id="VAR_058176" evidence="14">
<original>D</original>
<variation>G</variation>
<location>
<position position="666"/>
</location>
</feature>
<feature type="sequence variant" description="In myelodysplastic/myeloproliferative disorders; dbSNP:rs753786455." id="VAR_058135" evidence="13">
<original>S</original>
<variation>T</variation>
<location>
<position position="817"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs144386291." id="VAR_058177" evidence="13 14 16">
<original>Y</original>
<variation>H</variation>
<location>
<position position="867"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs4145756." id="VAR_039844">
<original>A</original>
<variation>G</variation>
<location>
<position position="912"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs34485921." id="VAR_058136" evidence="16">
<original>H</original>
<variation>R</variation>
<location>
<position position="924"/>
</location>
</feature>
<feature type="sequence variant" description="In a chronic myelomonocytic leukemia sample; somatic mutation; dbSNP:rs532738858." id="VAR_058178" evidence="14">
<original>P</original>
<variation>S</variation>
<location>
<position position="941"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs778464072." id="VAR_058137" evidence="16">
<original>H</original>
<variation>R</variation>
<location>
<position position="949"/>
</location>
</feature>
<feature type="sequence variant" id="VAR_058179" evidence="14">
<original>E</original>
<variation>V</variation>
<location>
<position position="1073"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs75056899." id="VAR_058180" evidence="13 14 16">
<original>Q</original>
<variation>P</variation>
<location>
<position position="1084"/>
</location>
</feature>
<feature type="sequence variant" description="In a myeloproliferative disorder; somatic mutation; dbSNP:rs769422572." id="VAR_058181" evidence="14">
<original>C</original>
<variation>Y</variation>
<location>
<position position="1135"/>
</location>
</feature>
<feature type="sequence variant" description="In a myelodysplatic/myeloproliferative disorder and a chronic myelomonocytic leukemia sample." id="VAR_058138" evidence="13">
<original>R</original>
<variation>T</variation>
<location>
<position position="1167"/>
</location>
</feature>
<feature type="sequence variant" description="In a refractory anemia with ringed sideroblasts sample." id="VAR_058139" evidence="15">
<original>I</original>
<variation>V</variation>
<location>
<position position="1175"/>
</location>
</feature>
<feature type="sequence variant" description="In a myeloproliferative disorder; somatic mutation." id="VAR_058182" evidence="14">
<original>S</original>
<variation>C</variation>
<location>
<position position="1204"/>
</location>
</feature>
<feature type="sequence variant" description="In a myelodysplastic syndrome; somatic mutation in a chronic myelomonocytic leukemia sample; dbSNP:rs761811530." id="VAR_058183" evidence="14 16">
<original>R</original>
<variation>W</variation>
<location>
<position position="1214"/>
</location>
</feature>
<feature type="sequence variant" description="In a polycythemia vera sample; somatic mutation." id="VAR_058140" evidence="15">
<location>
<begin position="1237"/>
<end position="1239"/>
</location>
</feature>
<feature type="sequence variant" description="Requires 2 nucleotide substitutions." id="VAR_058198" evidence="12">
<original>D</original>
<variation>R</variation>
<location>
<position position="1242"/>
</location>
</feature>
<feature type="sequence variant" description="In myeloproliferative disorders." id="VAR_058184" evidence="14">
<original>D</original>
<variation>V</variation>
<location>
<position position="1242"/>
</location>
</feature>
<feature type="sequence variant" description="In a myeloproliferative disorder; somatic mutation." id="VAR_058185" evidence="14">
<original>Y</original>
<variation>S</variation>
<location>
<position position="1245"/>
</location>
</feature>
<feature type="sequence variant" description="In a myeloproliferative disorder; somatic mutation; dbSNP:rs898441677." id="VAR_058186" evidence="14">
<original>R</original>
<variation>C</variation>
<location>
<position position="1261"/>
</location>
</feature>
<feature type="sequence variant" description="In a chronic myelomonocytic leukemia sample; somatic mutation; dbSNP:rs771761785." id="VAR_058187" evidence="14">
<original>R</original>
<variation>H</variation>
<location>
<position position="1261"/>
</location>
</feature>
<feature type="sequence variant" description="In a myelodysplastic syndrome." id="VAR_058141" evidence="16">
<original>R</original>
<variation>L</variation>
<location>
<position position="1261"/>
</location>
</feature>
<feature type="sequence variant" description="In a myelodysplastic syndrome; somatic mutation." id="VAR_058142" evidence="16">
<location>
<position position="1285"/>
</location>
</feature>
<feature type="sequence variant" description="In myelodysplastic/myeloproliferative disorders." id="VAR_058143" evidence="13">
<original>F</original>
<variation>L</variation>
<location>
<position position="1287"/>
</location>
</feature>
<feature type="sequence variant" description="In a myelodysplastic syndrome; somatic mutation; abolishes enzyme activity." id="VAR_058144" evidence="16 21">
<original>W</original>
<variation>R</variation>
<location>
<position position="1291"/>
</location>
</feature>
<feature type="sequence variant" description="In a refractory anemia sample." id="VAR_058145" evidence="15 21">
<original>K</original>
<variation>E</variation>
<location>
<position position="1299"/>
</location>
</feature>
<feature type="sequence variant" description="In chronic myelomonocytic leukemia samples." id="VAR_058146" evidence="13">
<original>K</original>
<variation>N</variation>
<location>
<position position="1299"/>
</location>
</feature>
<feature type="sequence variant" description="In primary myelofibrosis and chronic myelomonocytic leukemia samples." id="VAR_058147" evidence="13 15">
<original>R</original>
<variation>G</variation>
<location>
<position position="1302"/>
</location>
</feature>
<feature type="sequence variant" description="In chronic myelomonocytic leukemia samples." id="VAR_058148" evidence="13">
<original>E</original>
<variation>G</variation>
<location>
<position position="1318"/>
</location>
</feature>
<feature type="sequence variant" description="In a chronic myelomonocytic leukemia sample." id="VAR_058149">
<original>P</original>
<variation>S</variation>
<location>
<position position="1367"/>
</location>
</feature>
<feature type="sequence variant" description="In a myelodysplastic syndrome." id="VAR_058150" evidence="16">
<original>C</original>
<variation>W</variation>
<location>
<position position="1396"/>
</location>
</feature>
<feature type="sequence variant" description="In a myelodysplastic syndrome; somatic mutation." id="VAR_058151" evidence="16">
<original>L</original>
<variation>R</variation>
<location>
<position position="1398"/>
</location>
</feature>
<feature type="sequence variant" description="In a chronic myelomonocytic leukemia sample; somatic mutation; dbSNP:rs749210253." id="VAR_058188" evidence="14">
<original>V</original>
<variation>F</variation>
<location>
<position position="1417"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs62623390." id="VAR_058189" evidence="16">
<original>M</original>
<variation>I</variation>
<location>
<position position="1701"/>
</location>
</feature>
<feature type="sequence variant" description="In refractory anemia with ringed sideroblasts; somatic mutation in an acute myeloid leukemia sample; dbSNP:rs142312318." id="VAR_058190" evidence="13 14">
<original>V</original>
<variation>L</variation>
<location>
<position position="1718"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs34402524." id="VAR_058191" evidence="16">
<original>L</original>
<variation>W</variation>
<location>
<position position="1721"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs146348065." id="VAR_058192" evidence="14 16">
<original>P</original>
<variation>S</variation>
<location>
<position position="1723"/>
</location>
</feature>
<feature type="sequence variant" description="In a chronic myelomonocytic leukemia sample; somatic mutation." id="VAR_058152" evidence="14">
<original>H</original>
<variation>D</variation>
<location>
<position position="1757"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs2454206." id="VAR_058193" evidence="9 16">
<original>I</original>
<variation>V</variation>
<location>
<position position="1762"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs62621450." id="VAR_058194" evidence="16">
<original>H</original>
<variation>R</variation>
<location>
<position position="1778"/>
</location>
</feature>
<feature type="sequence variant" description="In a chronic myelomonocytic leukemia sample; somatic mutation." id="VAR_058153" evidence="14">
<original>C</original>
<variation>R</variation>
<location>
<position position="1811"/>
</location>
</feature>
<feature type="sequence variant" description="In a myeloproliferative disorder; somatic mutation." id="VAR_058154" evidence="14">
<original>Q</original>
<variation>L</variation>
<location>
<position position="1828"/>
</location>
</feature>
<feature type="sequence variant" description="In an essential thrombocythemia sample; dbSNP:rs1453845082." id="VAR_058155" evidence="15">
<original>G</original>
<variation>W</variation>
<location>
<position position="1869"/>
</location>
</feature>
<feature type="sequence variant" description="In a refractory anemia with excess blasts sample." id="VAR_058156" evidence="15">
<original>L</original>
<variation>P</variation>
<location>
<position position="1872"/>
</location>
</feature>
<feature type="sequence variant" description="In myelodysplastic syndromes, myeloproliferative disorders and chronic myelomonocytic leukemia; somatic mutation in acute myeloid leukemia and chronic myelomonocytic leukemia samples; dbSNP:rs116519313." id="VAR_058157" evidence="12 13 14 15 16">
<original>I</original>
<variation>T</variation>
<location>
<position position="1873"/>
</location>
</feature>
<feature type="sequence variant" description="In a myelodysplastic syndrome; somatic mutation." id="VAR_058195" evidence="16">
<original>C</original>
<variation>R</variation>
<location>
<position position="1875"/>
</location>
</feature>
<feature type="sequence variant" description="In a myelodysplastic syndrome; somatic mutation." id="VAR_058196" evidence="16">
<original>H</original>
<variation>Q</variation>
<location>
<position position="1881"/>
</location>
</feature>
<feature type="sequence variant" description="In a myeloproliferative disorder; somatic mutation; also in a patient with systemic mastocytosis associated with chronic myelomonocytic leukemia; dbSNP:rs1417392445." id="VAR_058158" evidence="11 14">
<original>H</original>
<variation>R</variation>
<location>
<position position="1881"/>
</location>
</feature>
<feature type="sequence variant" description="In a primary acute myeloid leukemia sample; somatic mutation; reduces enzyme activity." id="VAR_058159" evidence="15 21">
<original>R</original>
<variation>M</variation>
<location>
<position position="1896"/>
</location>
</feature>
<feature type="sequence variant" description="In a myeloproliferative disorder; somatic mutation." id="VAR_058197" evidence="16">
<original>R</original>
<variation>S</variation>
<location>
<position position="1896"/>
</location>
</feature>
<feature type="sequence variant" description="In a secondary acute myeloid leukemia sample; somatic mutation; loss of enzyme activity; dbSNP:rs767475870." id="VAR_058160" evidence="15 21">
<original>S</original>
<variation>F</variation>
<location>
<position position="1898"/>
</location>
</feature>
<feature type="sequence variant" id="VAR_058161" evidence="14">
<original>V</original>
<variation>A</variation>
<location>
<position position="1900"/>
</location>
</feature>
<feature type="sequence variant" description="In a myelodysplastic syndrome; somatic mutation." id="VAR_058162" evidence="16">
<location>
<begin position="1911"/>
<end position="1916"/>
</location>
</feature>
<feature type="sequence variant" description="In myelodysplastic syndromes; refractory cytopenia with multilineage dysplasia and ringed sideroblasts; somatic mutation in a patient." id="VAR_058163" evidence="13 16">
<original>G</original>
<variation>D</variation>
<location>
<position position="1913"/>
</location>
</feature>
<feature type="sequence variant" description="In a myeloproliferative disorder; somatic mutation; dbSNP:rs1163887807." id="VAR_058164" evidence="14">
<original>A</original>
<variation>V</variation>
<location>
<position position="1919"/>
</location>
</feature>
<feature type="sequence variant" description="In a chronic myelomonocytic leukemia sample; somatic mutation; dbSNP:rs1316795626." id="VAR_058165" evidence="14">
<original>R</original>
<variation>H</variation>
<location>
<position position="1926"/>
</location>
</feature>
<feature type="sequence variant" description="In a chronic myelomonocytic leukemia sample; somatic mutation; dbSNP:rs1283441077." id="VAR_058166" evidence="14">
<original>P</original>
<variation>S</variation>
<location>
<position position="1941"/>
</location>
</feature>
<feature type="sequence variant" description="In a myelodysplastic syndrome; dbSNP:rs200971953." id="VAR_058167" evidence="16">
<original>P</original>
<variation>L</variation>
<location>
<position position="1962"/>
</location>
</feature>
<feature type="sequence variant" description="In a chronic myelomonocytic leukemia sample; somatic mutation; dbSNP:rs754215085." id="VAR_058168" evidence="14">
<original>R</original>
<variation>H</variation>
<location>
<position position="1966"/>
</location>
</feature>
<feature type="sequence variant" description="In a chronic myelomonocytic leukemia sample; somatic mutation; dbSNP:rs1406914931." id="VAR_058169" evidence="14">
<original>R</original>
<variation>M</variation>
<location>
<position position="1974"/>
</location>
</feature>
<feature type="sequence variant" id="VAR_058170" evidence="14">
<original>R</original>
<variation>K</variation>
<location>
<position position="2000"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of enzyme activity." evidence="21">
<original>R</original>
<variation>G</variation>
<location>
<position position="1261"/>
</location>
</feature>
<feature type="mutagenesis site" description="Slightly reduces enzyme activity." evidence="21">
<original>R</original>
<variation>A</variation>
<location>
<position position="1262"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces enzyme activity; when associated with A-1295." evidence="21">
<original>S</original>
<variation>A</variation>
<location>
<position position="1290"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of enzyme activity." evidence="21">
<original>WSMYYN</original>
<variation>GGSGGS</variation>
<location>
<begin position="1291"/>
<end position="1296"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly reduced enzyme activity. Slightly decreased affinity for DNA." evidence="21">
<original>MY</original>
<variation>AA</variation>
<location>
<begin position="1293"/>
<end position="1294"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces enzyme activity; when associated with A-1290." evidence="21">
<original>Y</original>
<variation>A</variation>
<location>
<position position="1295"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of enzyme activity; when associated with E-1299." evidence="21">
<original>S</original>
<variation>N</variation>
<location>
<position position="1303"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of enzyme activity. Still able to enhance histone H2B GlcNAcylation by OGT; when associated with A-1384. Loss of enzyme activity; when associated with V-1384." evidence="19 21">
<original>H</original>
<variation>Y</variation>
<location>
<position position="1382"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of enzyme activity. Still able to enhance histone H2B GlcNAcylation by OGT; when associated with Y-1382." evidence="19 21">
<original>D</original>
<variation>A</variation>
<location>
<position position="1384"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of enzyme activity; when associated with Y-1382." evidence="19 21">
<original>D</original>
<variation>V</variation>
<location>
<position position="1384"/>
</location>
</feature>
<feature type="mutagenesis site" description="Near loss of enzyme activity." evidence="21">
<original>N</original>
<variation>A</variation>
<location>
<position position="1387"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of enzyme activity." evidence="21">
<original>Y</original>
<variation>A</variation>
<location>
<position position="1902"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of enzyme activity." evidence="21">
<original>H</original>
<variation>R</variation>
<location>
<position position="1904"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; BAA90898." ref="3" evidence="25">
<original>Q</original>
<variation>R</variation>
<location>
<position position="599"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; CAE45851." ref="1" evidence="25">
<original>H</original>
<variation>Q</variation>
<location>
<position position="702"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 4; BAE45750." ref="4" evidence="25">
<original>L</original>
<variation>S</variation>
<location>
<position position="878"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="1135"/>
<end position="1138"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="1141"/>
<end position="1144"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="1153"/>
<end position="1156"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="1157"/>
<end position="1168"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="1172"/>
<end position="1174"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="1175"/>
<end position="1182"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="1197"/>
<end position="1200"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="1209"/>
<end position="1215"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="1224"/>
<end position="1234"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="1238"/>
<end position="1255"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="1262"/>
<end position="1264"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="1278"/>
<end position="1280"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="1283"/>
<end position="1288"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="1293"/>
<end position="1296"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="1299"/>
<end position="1302"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="1312"/>
<end position="1314"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="1316"/>
<end position="1340"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="1342"/>
<end position="1348"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="1349"/>
<end position="1354"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="1356"/>
<end position="1358"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="1362"/>
<end position="1364"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="1370"/>
<end position="1376"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="1393"/>
<end position="1399"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="1401"/>
<end position="1403"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="1405"/>
<end position="1408"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="1416"/>
<end position="1418"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="1421"/>
<end position="1423"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="1432"/>
<end position="1440"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="1443"/>
<end position="1446"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="1451"/>
<end position="1459"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="1844"/>
<end position="1849"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="1851"/>
<end position="1855"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="1862"/>
<end position="1864"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="1871"/>
<end position="1874"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="1876"/>
<end position="1878"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="1881"/>
<end position="1883"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="1895"/>
<end position="1902"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="1904"/>
<end position="1906"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="1910"/>
<end position="1913"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="1914"/>
<end position="1920"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4NM6"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5D9Y"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5DEU"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19690332"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24129315"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q4JK59"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12646957"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17974005"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19262599"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19262601"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19372255"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19420352"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19474426"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19483684"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21057493"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21817016"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23222540"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23353889"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24315485"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="12880961"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="14702039"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="17974005"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000305"/>
<evidence key="26" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="21817016"/>
</source>
</evidence>
<sequence length="2002" mass="223811" checksum="6D740305EE2A8D46" modified="2009-06-16" version="3">MEQDRTNHVEGNRLSPFLIPSPPICQTEPLATKLQNGSPLPERAHPEVNGDTKWHSFKSYYGIPCMKGSQNSRVSPDFTQESRGYSKCLQNGGIKRTVSEPSLSGLLQIKKLKQDQKANGERRNFGVSQERNPGESSQPNVSDLSDKKESVSSVAQENAVKDFTSFSTHNCSGPENPELQILNEQEGKSANYHDKNIVLLKNKAVLMPNGATVSASSVEHTHGELLEKTLSQYYPDCVSIAVQKTTSHINAINSQATNELSCEITHPSHTSGQINSAQTSNSELPPKPAAVVSEACDADDADNASKLAAMLNTCSFQKPEQLQQQKSVFEICPSPAENNIQGTTKLASGEEFCSGSSSNLQAPGGSSERYLKQNEMNGAYFKQSSVFTKDSFSATTTPPPPSQLLLSPPPPLPQVPQLPSEGKSTLNGGVLEEHHHYPNQSNTTLLREVKIEGKPEAPPSQSPNPSTHVCSPSPMLSERPQNNCVNRNDIQTAGTMTVPLCSEKTRPMSEHLKHNPPIFGSSGELQDNCQQLMRNKEQEILKGRDKEQTRDLVPPTQHYLKPGWIELKAPRFHQAESHLKRNEASLPSILQYQPNLSNQMTSKQYTGNSNMPGGLPRQAYTQKTTQLEHKSQMYQVEMNQGQSQGTVDQHLQFQKPSHQVHFSKTDHLPKAHVQSLCGTRFHFQQRADSQTEKLMSPVLKQHLNQQASETEPFSNSHLLQHKPHKQAAQTQPSQSSHLPQNQQQQQKLQIKNKEEILQTFPHPQSNNDQQREGSFFGQTKVEECFHGENQYSKSSEFETHNVQMGLEEVQNINRRNSPYSQTMKSSACKIQVSCSNNTHLVSENKEQTTHPELFAGNKTQNLHHMQYFPNNVIPKQDLLHRCFQEQEQKSQQASVLQGYKNRNQDMSGQQAAQLAQQRYLIHNHANVFPVPDQGGSHTQTPPQKDTQKHAALRWHLLQKQEQQQTQQPQTESCHSQMHRPIKVEPGCKPHACMHTAPPENKTWKKVTKQENPPASCDNVQQKSIIETMEQHLKQFHAKSLFDHKALTLKSQKQVKVEMSGPVTVLTRQTTAAELDSHTPALEQQTTSSEKTPTKRTAASVLNNFIESPSKLLDTPIKNLLDTPVKTQYDFPSCRCVEQIIEKDEGPFYTHLGAGPNVAAIREIMEERFGQKGKAIRIERVIYTGKEGKSSQGCPIAKWVVRRSSSEEKLLCLVRERAGHTCEAAVIVILILVWEGIPLSLADKLYSELTETLRKYGTLTNRRCALNEERTCACQGLDPETCGASFSFGCSWSMYYNGCKFARSKIPRKFKLLGDDPKEEEKLESHLQNLSTLMAPTYKKLAPDAYNNQIEYEHRAPECRLGLKEGRPFSGVTACLDFCAHAHRDLHNMQNGSTLVCTLTREDNREFGGKPEDEQLHVLPLYKVSDVDEFGSVEAQEEKKRSGAIQVLSSFRRKVRMLAEPVKTCRQRKLEAKKAAAEKLSSLENSSNKNEKEKSAPSRTKQTENASQAKQLAELLRLSGPVMQQSQQPQPLQKQPPQPQQQQRPQQQQPHHPQTESVNSYSASGSTNPYMRRPNPVSPYPNSSHTSDIYGSTSPMNFYSTSSQAAGSYLNSSNPMNPYPGLLNQNTQYPSYQCNGNLSVDNCSPYLGSYSPQSQPMDLYRYPSQDPLSKLSLPPIHTLYQPRFGNSQSFTSKYLGYGNQNMQGDGFSSCTIRPNVHHVGKLPPYPTHEMDGHFMGATSRLPPNLSNPNMDYKNGEHHSPSHIIHNYSAAPGMFNSSLHALHLQNKENDMLSHTANGLSKMLPALNHDRTACVQGGLHKLSDANGQEKQPLALVQGVASGAEDNDEVWSDSEQSFLDPDIGGVAVAPTHGSILIECAKRELHATTPLKNPNRNHPTRISLVFYQHKSMNEPKHGLALWEAKMAEKAREKEEECEKYGPDYVPQKSHGKKVKREPAEPHETSEPTYLRFIKSLAERTMSVTTDSTVTTSPYAFTRVTGPYNRYI</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

